ConductScience.org, home

Paper37993201

Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction.

Butler J and 23 others. J Am Coll Cardiol, 2023. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction. Papers, record 37993201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37993201

Download JSON
Disease
obesity disorder354 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction.
PubMed
Journal
J Am Coll Cardiol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
6.72
iCite
Revised in PubMed
2026-01-27
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Butler JJaved
2Abildstrøm SZSteen Z
3Borlaug BABarry A
4Davies MJMelanie J
5Kitzman DWDalane W
6Petrie MCMark C
7Shah SJSanjiv J
8Verma SSubodh
9Abhayaratna WPWalter P
10Chopra VVijay
11Ezekowitz JAJustin A
12Fu MMichael
13Ito HHiroshi
14Lelonek MMałgorzata
15Núñez JJulio
16Perna EEduardo
17Schou MMorten
18Senni MMichele
19van der Meer PPeter
20von Lewinski DDirk

Source PubMed

See all 24 authorsDownload CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart FailureMajor topic
Humans
Stroke Volume
Ventricular Function, Left
Obesity
Semaglutide

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AG078153NIA NIH HHSUnited StatesR01AG078153PubMed and NIHNIH RePORTER
R01 AG018915NIA NIH HHSUnited StatesR01AG018915PubMed and NIHNIH RePORTER
R01 AG045551NIA NIH HHSUnited StatesR01AG045551PubMed and NIHNIH RePORTER
U01 AG076928NIA NIH HHSUnited StatesU01AG076928PubMed and NIHNIH RePORTER
U01 HL160272NHLBI NIH HHSUnited StatesU01HL160272PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04788511Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and ObesityDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in37993202Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure: STEPping Across the Ejection Fraction Divide.https://conductscience.org/library/papers/37993202

Source PubMed

Download CSV of comments and corrections

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137203441Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials.Circ Heart Fail2023https://conductscience.org/library/papers/37203441PubMed
224716680Spironolactone for heart failure with preserved ejection fraction.N Engl J Med2014https://conductscience.org/library/papers/24716680PubMed
337211977Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant-level pooled analysis from the DAPA-HF and DELIVER trials.Eur J Heart Fail2023https://conductscience.org/library/papers/37211977PubMed
429431256Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.Eur J Heart Fail2018https://conductscience.org/library/papers/29431256PubMed
531272568Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study.Mayo Clin Proc2019https://conductscience.org/library/papers/31272568PubMed
628381470Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.Circulation2017https://conductscience.org/library/papers/28381470PubMed
735500050Border Disputes Between Heart Failure Phenotypes.Circulation2022https://conductscience.org/library/papers/35500050PubMed
8344479922021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur Heart J2021https://conductscience.org/library/papers/34447992PubMed
936041474SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials.Lancet2022https://conductscience.org/library/papers/36041474PubMed
1013678871Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.Lancet2003https://conductscience.org/library/papers/13678871PubMed
1135379504
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
J Am Coll Cardiol2022https://conductscience.org/library/papers/35379504PubMed
1236994635Ventricular stiffening and chamber contracture in heart failure with higher ejection fraction.Eur J Heart Fail2023https://conductscience.org/library/papers/36994635PubMed
1337622681Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.N Engl J Med2023https://conductscience.org/library/papers/37622681PubMed
1426374849Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.Eur Heart J2016https://conductscience.org/library/papers/26374849PubMed
1537013269
A reclassification of heart failure based on recognition of heart failure with normal to supernormal ejection fraction, a clinically common form of cardiac contracture, with distinctive pathophysiological and therapeutic features.
Eur J Heart Fail2023https://conductscience.org/library/papers/37013269PubMed
1631736342Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.Circulation2020https://conductscience.org/library/papers/31736342PubMed
1727790809
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
Eur J Heart Fail2017https://conductscience.org/library/papers/27790809PubMed
1831475794Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.N Engl J Med2019https://conductscience.org/library/papers/31475794PubMed
1937643614A big STEP for treatment of heart failure with preserved ejection fraction.Cell Metab2023https://conductscience.org/library/papers/37643614PubMed
2034878502Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.Eur Heart J2022https://conductscience.org/library/papers/34878502PubMed

See all 25 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42985589Exploration of the Pathogenesis and Treatment of Heart Failure.Rev Cardiovasc Med2026https://conductscience.org/library/papers/42985589PubMed
42910211Cross-cutting circuits in heart failure with preserved ejection fraction: Integrating adipokine biology, mechanotransduction, and precision targeting.Int J Biol Sci2026https://conductscience.org/library/papers/42910211PubMed
42866227Bidirectional metabolic-vascular feedback loops in heart failure: From myocardial energetics to multisystem cardiometabolic crosstalk.iScience2026https://conductscience.org/library/papers/42866227PubMed
42737629Mitochondrial Distress Signals at the Heart-Liver Interface: Molecular Links Between MASLD and Heart Failure.Int J Mol Sci2026https://conductscience.org/library/papers/42737629PubMed
42533336Metabolic disorder-MASLD-cardiovascular disease-kidney disease (MMCK) syndrome: an expansion of the Cardiovascular-Kidney-Metabolic (CKM) framework.Cardiovasc Diabetol Endocrinol Rep2026https://conductscience.org/library/papers/42533336PubMed
42292836Metabolic dysfunction-associated steatotic liver disease and heart failure with preserved ejection fraction: mechanisms and clinical implications from a heart-liver metabolic axis perspective.Front Pharmacol2026https://conductscience.org/library/papers/42292836PubMed
42280332GLP-1 Receptor Agonists in the Rehabilitation of Patients with Heart Failure: Mechanisms, Clinical Evidence, and Future Perspectives.Nutrients2026https://conductscience.org/library/papers/42280332PubMed
42213282Metabolic inflexibility across heart failure phenotypes: mechanisms and type-specific therapeutic implications.Apoptosis2026https://conductscience.org/library/papers/42213282PubMed
42210124Semaglutide in non-diabetic obese Chinese patients with acute coronary syndrome: a multicenter retrospective study.BMC Cardiovasc Disord2026https://conductscience.org/library/papers/42210124PubMed
42194729Glucagon-like Peptide-1 Therapy in Obesity-Related Heart Failure with Preserved Ejection Fraction: Mechanisms, Clinical Evidence, and Implications.J Clin Med2026https://conductscience.org/library/papers/42194729PubMed
42025516Heart Failure With Mildly Reduced Ejection Fraction: A Heart Failure Society of America Scientific Statement.J Card Fail2026https://conductscience.org/library/papers/42025516PubMed
41939833Alpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure.Front Pharmacol2026https://conductscience.org/library/papers/41939833PubMed
41733759Obesity medications and precision nutrition: synergistic interventions and integrated approach in obesity management.Curr Obes Rep2026https://conductscience.org/library/papers/41733759PubMed
41653275GLP-1 Mitigated Inflammation and Oxidative Stress in Oral Lichen Planus Via JAK-STAT3 Pathway.Biochem Genet2026https://conductscience.org/library/papers/41653275PubMed
41566974Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management.Endocrinol Diabetes Metab2026https://conductscience.org/library/papers/41566974PubMed
41501059Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases.Nat Commun2026https://conductscience.org/library/papers/41501059PubMed
413791772025 Brazilian Evidence-based Guideline on the Management of Obesity and Prevention of Cardiovascular Disease and Obesity-Associated Complications: A Position Statement by Five Medical Societies.Arq Bras Cardiol2025https://conductscience.org/library/papers/41379177PubMed
41304969Potential Implications of Body Mass Composition Changes in Heart Failure Patients in the Era of SGLT2i, GLP-1 RA, and GIP/GLP-1 RA.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41304969PubMed
412547912025 Brazilian evidence-based guideline on the management of obesity and prevention of cardiovascular disease and obesity-associated complications: a position statement by five medical societies.Diabetol Metab Syndr2025https://conductscience.org/library/papers/41254791PubMed
41195790Role of GLP-1 Receptor Agonists in Managing Cancer Therapy-Related Cardiac Dysfunction.J Am Heart Assoc2025https://conductscience.org/library/papers/41195790PubMed

See all 43 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401

Source NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
SEMAGLUTIDECHEMBL2108724Derived from the trial1https://conductscience.org/library/drugs/CHEMBL2108724

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37993201

GET https://conductscience.org/api/papers/v1/37993201/authors?page=2